Loading...
Neoadjuvant therapy for gastrointestinal stromal tumor
Molecular-targeting therapy using tyrosine kinase inhibitor imatinib mesylate is effective for metastasis/recurrent gastrointestinal stromal tumors (GISTs). Likewise, imatinib would be effective in the neoadjuvant therapy for high-risk GIST. Neoadjuvant therapy may have the potential to increase the...
Na minha lista:
| Udgivet i: | Transl Gastroenterol Hepatol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AME Publishing Company
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5803029/ https://ncbi.nlm.nih.gov/pubmed/29441368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tgh.2018.01.01 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|